“…Second generation rapid assays are also now available for point-of-care diagnosis (Chaiyaratana et al, 2009;Hang et al, 2009;Zainah et al, 2009). All of these tests have now been subjected to a large number of field evaluations that have proven the value of the assay in the early diagnosis of dengue infection (Anders et al, 2012;Arya et al, 2011a, b;Bessoff et al, 2008;Blacksell et al, 2012a;Blacksell et al, 2012b;Blacksell et al, 2008;Chaiyaratana et al, 2009;Dussart et al, 2008;Fry et al, 2011;Gowri Sankar et al, 2012;Gupta et al, 2012;Hsieh and Chen, 2009;Kumarasamy et al, 2007a;Kumarasamy et al, 2007b;Lapphra et al, 2008;Lemes et al, 2005;Ludert et al, 2008;McBride, 2009;Muller et al, 2012a;Phuong et al, 2009;Shu et al, 2009;Simmons et al, 2007;Tricou et al, 2011;Xu et al, 2006;Zainah et al, 2009). The commercial development and application of NS1 detection as a diagnostic tool has revolutionised dengue diagnosis as it now provides a simple and relatively low cost assay that has high sensitivity and specificity (Castro-Jorge et al, 2010;Lima Mda et al, 2010;Wang and Sekaran, 2010b).…”